Final answer:
Following the 1980 Diamond v. Chakrabarty case, genetically modified organisms can be patented if they are novel, man-made, and not naturally occurring. Therefore, Min-Ja Industries could potentially have their patent for a new form of bacteria granted if it meets these criteria.
Step-by-step explanation:
Historically, living organisms were not considered patentable as they were naturally occurring. However, a landmark case in 1980, Diamond v. Chakrabarty, changed this perspective when the U.S. Supreme Court ruled that a genetically modified bacterium could be patented because it was man-made and not a product of nature. This paved the way for individuals and entities to own genetically modified organisms (GMOs) and secure patents for their unique genetic modifications. Therefore, if Min-Ja Industries has developed a new, novel form of bacteria that is not naturally occurring and is a result of their own genetic manipulation, their patent application has a potential to be granted, assuming all other patent criteria are met.